by Jessica Etheridge | Aug 27, 2024 | Company Details, News and Events
August 26, 2024 | Tom Ballard It’s been a whirlwind year for New Day Diagnostics While seeing its cancer diagnostic work to fruition, the future is becoming a national leader in clinical trial management along with contract research. The last 12 months or so for the...
by Jessica Etheridge | Apr 18, 2024 | Company Details
HUMAN RESOURCES AND OPERATIONS MANAGER – Knoxville, TN (On-site Only) About the Job Reporting to the Chief Operating Officer, the Human Resources and Operations Manager at New Day Diagnostics. plays a pivotal role in managing the daily operations and administrative...
by Jessica Etheridge | Sep 14, 2023 | Company Details, News and Events
KNOXVILLE, Tenn., September 14, 2023–New Day Diagnostics is pleased to announce that the Extraordinary General Meeting of Epigenomics AG (Frankfurt General Standard: ECX1), a molecular diagnostics company focused on blood testing for the early detection of...
by Jessica Etheridge | Aug 20, 2023 | Company Details
Dr. Bergein Overholt is widely recognized for his work as the developer of the flexible fiber sigmoidoscope-colonoscope in 1963, which is used in colonoscopy while serving in the Cancer Control Program of the U.S. Public Health Service. For his innovative work, he was...
by Jessica Etheridge | Aug 20, 2023 | Company Details
Dr. Herbert Fritsche is Professor of Laboratory Medicine and Chief of the Clinical Chemistry Section at The University of Texas, M.D. Anderson Cancer Center in Houston, Texas. During his 40+ years at M.D. Anderson Cancer Center, Dr. Herbert Fritsche has focused his...
by Jessica Etheridge | Aug 20, 2023 | Company Details
Eric Allyn will be a non-Director Board Observer and is the former Chairman of the Board of Directors of Welch Allyn, Inc, a company owned by the Allyn Family for 100 years. In September of 2015, as a result of tremendous consolidation in health care, Welch Allyn sold...
